Back to Results
First PageMeta Content
Neurology / Auspex / Medicine / Movement disorder / Glatiramer acetate / Rasagiline / Amyotrophic lateral sclerosis / Science and technology in Israel / Health / Teva Pharmaceutical Industries


Teva buying Auspex for $3.2 billion
Add to Reading List

Document Date: 2015-05-10 14:07:10

Open Document

File Size: 14,51 KB

Share Result on Facebook
UPDATE